ingredient Eribulin Mesylate 0.5mg
substitutes Eribulin Mesylate 0.5mg
treatment Treatment of Metastatic breast cancer.
Shipping class Room Temperature
Medicine Overview by Anukar Pharmacy
( Halaven 0.5 mg Injection, Eisai )
TreatmentHalaven 0.5 mg Injection is used in the treatment of Metastatic breast cancer.
Side EffectsAnemia (low number of red blood cells), Weakness, Hair loss, Nausea, Constipation, Decreased white blood cell count, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand)
Method of UseYour doctor or nurse will give you this medicine. Kindly do not self administer.
How Halaven 0.5 mg Injection, Eisai WorksHalaven 0.5 mg Injection is an anticancer medication. It works by interfering with the microtubule structures which help the cancer cells to divide and multiply. This slows the growth of cancer cells and eventually kills them.
More Info by Anukar Pharmacy
( Halaven 0.5 mg Injection, Eisai )
Suggestions
- Halaven 0.5 mg Injection helps treat breast cancer that has spread to other areas of the body.
- It is given by an injection into a vein (intravenously).
- It may cause dizziness and tiredness. Do not drive or do anything requiring concentration until you know how it affects you.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for three months after you stop taking it.
- Your doctor may get regular blood tests done to monitor your blood cells and electrolyte levels during treatment with this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea while taking this medicine.
- It may cause numbness, tingling or pricking sensations in your hands and feet. Inform your doctor if this bothers you.
Warning by Anukar Pharmacy
( Halaven 0.5 mg Injection, Eisai )
Special precautions for Halaven 0.5 mg Injection, Eisai Heads up
| aspect | highlight | details |
|---|---|---|
Alcohol
|
There is no data available. Please consult doctor before consuming the drug. | |
Pregnancy
|
WEIGH RISKS VS BENEFITS | Halaven 0.5 mg Injection is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor. |
Lactation
|
Halaven 0.5 mg Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable. | |
Driving
|
There is no data available. Please consult doctor before consuming the drug. | |
Kidney
|
There is no data available. Please consult doctor before consuming the drug. | |
Liver
|
There is no data available. Please consult doctor before consuming the drug |
Suggestion by Anukar Pharmacy on missing a dose
( Halaven 0.5 mg Injection, Eisai )
If you miss a dose, kindly inform your doctor.
Disclaimer
The information of Anukar Pharmacy is for reference purpose only, and Anukar Pharmacy or Anukar Pharmacy or Anukar Pharmacy is not intended to be a replacement of professional medical advice, diagnosis, or treatment. Anukar Pharmacy suggest to ask the advice of a physician or any qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of anything you have learned from Anukar Pharmacy.
| 药名 | 海乐卫, 艾立布林, 艾日布林, 艾瑞布林 |
| 厂家 | 日本卫材 |
| 成分 | Eribulin0.5mg |
| 说明 |
艾立布林
艾立布林（Eribulin）是一种软海绵素类微管动力学抑制剂，提取自日本神奈川县油壶之地的冈田软海绵素B(Halichondrin B)。由日本卫材制药研发。Halaven 1mg 注射液用于治疗乳腺癌。它用于治疗已经扩散到身体其他部位的乳腺癌成人，以及在癌症扩散后已经接受过其他抗癌药物的成人。
治疗作用：适应于转移性乳腺癌
|
* 以上中文信息由印度阿努卡药房收集的Halaven 0.5 mg Injection, Eisai（海乐卫, 艾立布林, 艾日布林, 艾瑞布林）中文网络信息和软件翻译获得，阿努卡药房认为Halaven 0.5 mg Injection, Eisai（海乐卫, 艾立布林, 艾日布林, 艾瑞布林）中文产品介绍信息存在与Halaven 0.5 mg Injection, Eisai（海乐卫, 艾立布林, 艾日布林, 艾瑞布林）实际数据不一致的可能。阿努卡药房请用户把Halaven 0.5 mg Injection, Eisai（海乐卫, 艾立布林, 艾日布林, 艾瑞布林）页面数据作为参考。印度阿努卡药房建议用户在实际使用Halaven 0.5 mg Injection, Eisai（海乐卫, 艾立布林, 艾日布林, 艾瑞布林）数据或者信息时，以Halaven 0.5 mg Injection, Eisai（海乐卫, 艾立布林, 艾日布林, 艾瑞布林）制造商公开发布的Halaven 0.5 mg Injection, Eisai（海乐卫, 艾立布林, 艾日布林, 艾瑞布林）商品信息为参考。使用方法，以用户医生建议使用Halaven 0.5 mg Injection, Eisai（海乐卫, 艾立布林, 艾日布林, 艾瑞布林）决定为参考。用户任何关于Halaven 0.5 mg Injection, Eisai（海乐卫, 艾立布林, 艾日布林, 艾瑞布林）的建议，可以通知印度阿努卡药房，或通知阿努卡在线客服人员。谢谢
